FDA data Registry peer set 4 peers FDA shortage listed

Alternatives to moxifloxacin

FDA shortage status is active for moxifloxacin; 4 same-class SPL records are listed below for registry comparison only.

Brand: Avelox

Fluoroquinolone Antibiotic Prescription 4 alternatives found

moxifloxacin class peers while FDA lists an active shortage

moxifloxacin (Avelox) is on an FDA shortage listing while 4 other Fluoroquinolone Antibiotic SPL records remain in this registry peer set (class inventory 5). Labeled indication field for moxifloxacin: Moxifloxacin treats infections like pneumonia, skin infections, and infections in your stomach area.

Top FAERS reaction fields for moxifloxacin total 9,399 reports across 10 reactions, set beside ciprofloxacin, delafloxacin, levofloxacin. Counts are exposure-weighted submissions, not per-patient risk.

About moxifloxacin

Moxifloxacin is an antibiotic that fights bacteria in your body. It is used to treat different types of infections.

Used for: Moxifloxacin treats infections like pneumonia, skin infections, and infections in your stomach area. It can also treat sinus infections, bronchitis, and plague. This medicine should only be used to treat infections that are proven or very likely to be caused by bacteria that it can kill.

4 Fluoroquinolone Antibiotic peers (wide set)

Compare moxifloxacin vs ciprofloxacin side-by-side →

moxifloxacin vs ciprofloxacin & delafloxacin · FAERS reaction fields

FAERS top-reaction field "Drug Hypersensitivity" shows the widest count spread between moxifloxacin and ciprofloxacin, delafloxacin, levofloxacin in this extract (4,600-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect moxifloxacin ciprofloxacindelafloxacinlevofloxacin
Dyspnoea 1,225 4,098 - 2,950
Pneumonia 1,142 - - 2,863
Vomiting 1,101 3,723 - 1,878
Drug Hypersensitivity 1,073 5,673 - 1,746
Asthma 910 - - -
Pain 832 5,587 - 2,424
Nausea 814 5,298 - 2,790
Wheezing 795 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

moxifloxacin shortage vs Fluoroquinolone Antibiotic peer index

Shortage status

FDA shortage listing is active for moxifloxacin (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for moxifloxacin while peers remain indexed?
Yes - moxifloxacin matched an active FDA shortage listing (To Be Discontinued) while 4 other Fluoroquinolone Antibiotic SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full moxifloxacin profile →

Field note for moxifloxacin: see also the generic vs brand label guide when reading Avelox SPL strings.